STXS — Stereotaxis Income Statement
0.000.00%
- $173.68m
- $166.81m
- $26.92m
Annual income statement for Stereotaxis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 26.6 | 35 | 28.1 | 26.8 | 26.9 |
Cost of Revenue | |||||
Gross Profit | 19 | 23.2 | 18.5 | 14.9 | 14.6 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 33.3 | 45.7 | 46.9 | 48.6 | 51.7 |
Operating Profit | -6.71 | -10.7 | -18.8 | -21.8 | -24.7 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.65 | -10.7 | -18.3 | -20.7 | -24 |
Provision for Income Taxes | |||||
Net Income After Taxes | -6.65 | -10.7 | -18.3 | -20.7 | -24 |
Net Income Before Extraordinary Items | |||||
Net Income | -6.65 | -10.7 | -18.3 | -20.7 | -24 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.02 | -12.1 | -19.6 | -22.1 | -25.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.11 | -0.189 | -0.258 | -0.273 | -0.298 |